Homebuilding ETFs Are on Fire
by Leslie N. Masonson, MBA Since November 15th, the home building companies have been among the best performers on the VectorVest Stock and ETF Viewers. This is not surprising based on the large demand for housing that can’t keep up with the number of buyers looking to move or upgrade their housing needs. The increase in mortgage rates over [...]
Scholastic Falls 12% on Weak Earnings and Guidance, But It’s Not Time to Cut Losses Yet
Scholastic Corporation (SCHL) reported Q2 earnings Thursday after the bell, sending shares lower in extended trading. They pick up where they left off Friday morning when the market opened, falling 12% so far. This came after the company, which offers resources and tools for educators, families, and kids themselves, reported disappointing results for the second quarter of the year [...]
What is Paper Trading?
Getting started investing can be daunting. Even if you’ve invested time and energy into learning technical analysis and learning fundamental analysis, actually using these newfound skills in real-time scenarios is stressful. The fear of losses often overshadows the thrill of potential gains. So, you end up stuck in what is called analysis paralysis - never actually putting your abilities to [...]
Vivendi Climbs 4% on Plans to Split Into 3 Distinct Entities: Should You Buy Shares Before it Happens?
Vivendi (VIVHY) is a French media conglomerate that you may not be familiar with yet, but you will be soon. The company announced today that it is looking at the possibility of splitting itself into 3 distinct entities: Public relations and advertising company Havas Filmmaker Groupe Canal+ An investment company for its majority stake in Lagardère Group, a publishing [...]
AMC Shows More Financial Cracks After Equity Offering
Not even the wildly successful Taylor Swift partnership could lift AMC Entertainment Holdings Inc. from a continual downturn. The most recent event was noted on Tuesday, December 12th, as the company dropped 5% in shares following the completion of its latest equity offering. The offering raised $350 million by selling around 48 million shares at an average price of [...]
Pfizer Falls to 10-Year Low on Weak Forecast for 2024: 3 Reasons to Sell This Stock ASAP
Pfizer (PFE) fell 9% in Wednesday morning trading after the company’s weak forecast for 2024 left much to be desired in the eyes of investors and analysts alike. The stock is headed toward a 10-year low, and has now shed 50% of its value in the last year alone. The drugmaker has been steadily losing its footing since the [...]
